Simplified silvestrol analogues with potent cytotoxic activity

Area of Science:

• Natural product chemistry
• Molecular biology
• Cancer research

Background:

• Silvestrol (1) and episilvestrol (2) are natural products that inhibit translation initiation by binding to eukaryotic initiation factor 4A (eIF4A).
• Both compounds exhibit potent in vitro cytotoxicity against cancer cells, with compound 1 showing in vivo efficacy in cancer models.

Purpose of the Study:

• To investigate the drug-like properties of episilvestrol (2) and develop novel analogues of silvestrol and episilvestrol with improved pharmaceutical characteristics.
• To evaluate the anti-cancer potential of these new analogues.

Main Methods:

• Assessment of plasma membrane permeability and metabolic stability of episilvestrol (2).
• Synthesis of analogues by replacing the pseudo-sugar moiety of silvestrol/episilvestrol with simpler chemical groups.
• Evaluation of compound activity in biochemical and cellular translation assays.
• Testing of selected analogues against leukemia cell lines.

Main Results:

• Episilvestrol (2) exhibits limited plasma membrane permeability and undergoes metabolism in liver microsomes, similar to silvestrol (1).
• The synthesized analogues demonstrated improved drug-like properties.
• Several analogues showed potent activity in translation inhibition assays and significant cytotoxicity against leukemia cell lines.

Conclusions:

• Chemical modification of silvestrol and episilvestrol can yield analogues with enhanced drug-like properties and potent anti-leukemia activity.
• These findings support the development of silvestrol/episilvestrol derivatives as potential therapeutic agents for cancer treatment.